The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy

Abstract

In patients with higher risk of local recurrence, surveillance with MRI may represent an effective surveillance strategy though subgroups benefiting have not been identified nor has the impact on quality of life and cost been evaluated.

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

“…In case of increased risk such as age <50 years, HR negativity, and decreased diagnostic accessibility C/D in MG and US, MRI should be considered [102]. In this context, screening for secondary malignancies according to guidelines is meaningful.…”

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

“…In case of increased risk such as age <50 years, HR negativity, and decreased diagnostic accessibility C/D in MG and US, MRI should be considered [84].…”

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

“…Unfortunately, there are still no data that would support tailoring breast cancer follow-up according to molecular subtype. In case of increased risk such as age <50 years, HR negativity, and decreased diagnostic accessibility C/D in MG and ultrasound, magnetic resonance imaging should be considered [102]. In this context, screening for secondary malignancies according to guidelines is meaningful.…”